Compugen Stock Performance
| CGEN Stock | USD 1.76 0.05 2.92% |
On a scale of 0 to 100, Compugen holds a performance score of 3. The firm shows a Beta (market volatility) of 1.02, which signifies a somewhat significant risk relative to the market. Compugen returns are very sensitive to returns on the market. As the market goes up or down, Compugen is expected to follow. Please check Compugen's total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Compugen's price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Compugen are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Compugen may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
1 | Compugen Launches Business Unit to Help Canadian Organizations Maximize Value on Microsoft Investments | 11/13/2025 |
2 | Compugen Raised to Hold at Wall Street Zen | 11/17/2025 |
3 | Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to 90 Million | 12/17/2025 |
4 | TIGIT Inhibitors Drugs Clinical Trials Global Market Opportunity Report 2026-2030 Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnol... | 01/06/2026 |
5 | Compugen Partners with AXL to Support Canadas AI Commercialization | 01/26/2026 |
6 | AstraZeneca results FY and Q4 2025 | 02/10/2026 |
| Begin Period Cash Flow | 14.3 M | |
| Total Cashflows From Investing Activities | -46.3 M |
Compugen Relative Risk vs. Return Landscape
If you would invest 165.00 in Compugen on November 13, 2025 and sell it today you would earn a total of 11.00 from holding Compugen or generate 6.67% return on investment over 90 days. Compugen is currently generating 0.1952% in daily expected returns and assumes 4.2747% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Compugen, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Compugen Target Price Odds to finish over Current Price
The tendency of Compugen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.76 | 90 days | 1.76 | about 38.75 |
Based on a normal probability distribution, the odds of Compugen to move above the current price in 90 days from now is about 38.75 (This Compugen probability density function shows the probability of Compugen Stock to fall within a particular range of prices over 90 days) .
Compugen Price Density |
| Price |
Predictive Modules for Compugen
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Compugen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Compugen Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Compugen is not an exception. The market had few large corrections towards the Compugen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Compugen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Compugen within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 1.02 | |
σ | Overall volatility | 0.21 | |
Ir | Information ratio | 0.02 |
Compugen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Compugen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Compugen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Compugen may become a speculative penny stock | |
| Compugen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 513 K. | |
| Latest headline from finance.yahoo.com: AstraZeneca results FY and Q4 2025 |
Compugen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Compugen Stock often depends not only on the future outlook of the current and potential Compugen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Compugen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 89.5 M | |
| Cash And Short Term Investments | 103.3 M |
Compugen Fundamentals Growth
Compugen Stock prices reflect investors' perceptions of the future prospects and financial health of Compugen, and Compugen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugen Stock performance.
| Return On Equity | -0.53 | ||||
| Return On Asset | -0.18 | ||||
| Operating Margin | (4.17) % | ||||
| Current Valuation | 72.52 M | ||||
| Shares Outstanding | 93.54 M | ||||
| Price To Earning | (4.86) X | ||||
| Price To Book | 3.65 X | ||||
| Price To Sales | 23.32 X | ||||
| Revenue | 27.86 M | ||||
| Gross Profit | 513 K | ||||
| EBITDA | (14.4 M) | ||||
| Net Income | (14.23 M) | ||||
| Cash And Equivalents | 88.21 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 2.91 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 6.16 X | ||||
| Book Value Per Share | 0.47 X | ||||
| Cash Flow From Operations | 49.6 M | ||||
| Earnings Per Share | (0.30) X | ||||
| Market Capitalization | 160.97 M | ||||
| Total Asset | 115 M | ||||
| Retained Earnings | (488.76 M) | ||||
| Working Capital | 85.84 M | ||||
| Current Asset | 53.09 M | ||||
| Current Liabilities | 8.38 M | ||||
About Compugen Performance
By examining Compugen's fundamental ratios, stakeholders can obtain critical insights into Compugen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Compugen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (426.03) | (447.34) | |
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.14) | (0.15) | |
| Return On Assets | (0.14) | (0.15) | |
| Return On Equity | (0.30) | (0.31) |
Things to note about Compugen performance evaluation
Checking the ongoing alerts about Compugen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Compugen may become a speculative penny stock | |
| Compugen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 513 K. | |
| Latest headline from finance.yahoo.com: AstraZeneca results FY and Q4 2025 |
- Analyzing Compugen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugen's stock is overvalued or undervalued compared to its peers.
- Examining Compugen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Compugen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Compugen's stock. These opinions can provide insight into Compugen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.